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Abstract: The purpose of this study was to determine neurotransmitter and vitamin D3 levels in both 
men and women. Fifty healthy middle-aged men and women of 41.17 ± 9.6 and 42 ± 9.59 years 
respectively were selected. They have no known disease. While 50 male and female diabetic patients 
with an average age of 55.5 ± 14.92 and 47.87 ± 10.81 years were selected respectively. 
Anthropological data, including age, weight and length, were recorded in both controls and patients. 
To test the hypothesis of study relationship between vitamin D and neurotransmitters was analyzed 
in both groups. The statistical significance was taken at the p-level <0.05. The diabetic patients had 
neuropathy for 3 to 5 years with high HbA1c. Age and gender do not significantly affect neuropathy 
in diabetes. The average standard deviation of vitamin D3 is significantly lower in those having 
diabetic neuropathies, 12,448 ± 3,519 ng / ml (SD), which is not 24,958 ± 5,419 ng / ml, and was 
compared with vitamin D3 neuropathy in patients who did not have diabetes. (p <0.01). This analysis 
has shown that the neuropathy of diabetes is strongly linked to vitamin D3 after including confusion 
such as "Duration of diabetes and HbA1c". In patients with diabetes, the effects of vitamin D3 on 
neuropathy and the need for further studies ensure that there is a delay in preventing the dose of 
vitamin D3 or in the onset of neuropathy due to diabetes 
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Diabetic neuropathy influences neurons of the fringe sensory system as well as tangible, autonomic neurons leaving it 
powerless [1]. Other than this, each organ framework in the body that depends on innervations for capacity is  
therefore subject to pathology [1]. Consequently diabetic neuropathy portrays various unmistakable disorders that are 
for the most part arranged by the nerve strands influenced. Concerning the malady course, it is blessed that just a 
minority of patients experience neuropathic agony yet terrible that a lion's share don't report side effects until the 
difficulties are extreme [1]. 
Pervasiveness information for Diabetic Autonomic Neuropathy (DAN) range from 1.6 to 90% contingent upon 
tests utilized, populaces inspected, sort and phase of sickness. Danger components for the advancement of DAN 
incorporate diabetes’ length of time, age, and Long-term regulation of low blood sugar. Large pots can be separated 
by elements of events such as high pulses and dyslientemia. High glycemic control, fat control and blood pressure 
regulation may be important in the interactive DNA process. Many years of exploration clarifying that the patho-
physiology of diabetic neuropathy has been fizzled, in this manner there is a critical need to create a treatment that 
anticipates or switches its improvement and movement [2]. As of late, various contending or parallel obsessive 
pathways have started to cross and supplement one another, lighting up potential pharmacologic targets. The ebb 
and flow center of diabetic neuropathy exploration are oxidative anxiety, propelled glycation deciding items, that is, 
Advanced Glycation End Products (AGEs), protein C kinase (PKC) and the polyol pathway [2]. In 1986, an 
important part of vitamin D in the endocrine pancreas was identified; essentially, inadequate vitamin D has been 
shown to secrete insulin in the pancreas [3]. Scientists have discovered that the relationship between vitamin D and 
diabetes is detected in the future by vitamin D, vitamin D receptor (VDR), atomic pancreatic tissue, visual 
explanation, and the ability to respond to the future of vitamin D [4]. Data from different countries, such as South 
India, Germany and Taiwan, have been shown to be related to polymorphism of vitamin D receptors and type 1 
diabetes [5, 6, 7]. DBP and VDR polymorphism is related to glucose capacity and the severity of type 2 diabetes 
with age, lifestyle and diversity [8]. VDR gene is located on chromosome 12q13.11 and consists of 11 exons. Most 
VDR polymorphisms [9], in several forms of relationship between several observational studies reported an effect 
on glucose insulin and calcitriol levels [10]. A study confirmed that T2D patients with AA genotype had slightly 
higher plasma glucose levels and those having Aa and AA mutants, but were non-diabetics had significantly higher 
plasma glucose levels which was associated with insulin resistance [11]. 
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MATERIALS AND METHOD 
 
A. Patients and Method 
 
A cross sectional study approved by ethics committee of Baqai Medical University, was done in the 
Department of Physiology at Baqai Medical College and affiliated Baqai Hospitals (Fatima & North 
Nazimabad), Karachi and Jinnah Postgraduate Medical Centre, Karachi. Duration of the study was from 
August 2014 to March 2015. The study included 50 patients (Males & females) with mean ages 
55.5±14.92 and 47.87±10.81 years respectively and 50 normal subjects (males and females) with mean 
ages 41.17±9.66 and 42±9.59 years respectively. The information regarding name, age, sex, height 
(centimeter) and weight (kg) was filled on a consented questionnaire. Nerve conduction velocity was 




After Venipuncture blood was collected in Potassium EDTA, Ammonium Heparin or Lithium Heparin 
anticoagulants tubes. The determination of HbA1c is based on a latex agglutination inhibition assay (Kit 
Randox Laboratories Limited). The agglutinator has an artificial polymer that contains several copies of 
the HbA1c's immune molecule, which causes the latex binding of monoclonal antibody in the mouse 
HBA1c [12]. The appearance of HbA1c in the sample will slow down the stacking rate because it 
competes with the HbA1C integrator for antibody binding sites on latex. The percentage HbA1c is then 
calculated using the g/dl HbA1c and Total Hemoglobin values [13].  
 
C. Nerve conduction velocity 
 
The motor nerve conduction study, a mixed nerve containing motor and sensory axons is stimulated at a 
given site along its course. The stimulus is a brief electrical pulse which will induce a sufficient 
depolarization in all the axons under this site to generate action potentials [14]. The evoked potentials in 
motor axons will travel in distal and proximal directions from the stimulus site. The action potentials 
travelling towards the muscle innervated by that nerve will reach the neuromuscular synapses after some 
milliseconds and will induce their neuromuscular transmission and eventually action potentials along the 
muscle fibers. The summation of these muscle fiber action potentials is recorded by surface electrodes 
placed on the skin over the muscle and is known as compound muscle action potential (CMAP) [15]. The 
onset latency of the CMAP reflects the conduction time along the fastest conducting axons of the nerve. 
When the nerve is stimulated at increasing distances from the muscle (e.g. wrist, elbow, axilla, and Erb’s 
point), CMAPs of increasing latencies are recorded. The amplitude and area of the CMAP reflect the 
number of muscle fiber action potentials and therefore indirectly, the number of axons which can be 
stimulated [16]. However, as in nerve pathology some axons may be affected whereas other axons are 
normal, it is more convenient to describe the CMAP as the summation of motor unit action potentials 
(MUPs) rather than as the summation of muscle fiber action potentials. A MUP is the summation of the 
muscle fiber action potentials of one motor unit. A motor unit is one motor neuron, including its axon, and 
the muscle fibers it innervates [17]. 
 




Tc= conduction time 
 
Nerve conduction velocity was measured in Motor nerves which include Median nerve, Ulnar Nerve, 
Tibial Nerve and Peroneal nerve and sensory nerves including Radial Nerve, Ulnar Nerve and Sural 
nerve. 
 
D. Vitamin D 
 
Enzyme Linked Immunosorbent Assay was done on microtiter plates. The required numbers of strips 
were selected to run ELISA kit. The unused strips were resealed in the bag with a desiccant and stored 
at 2-8°C [18]. 50 μl of each Calibrator, Control and Sample were pipetted into the appropriate wells 
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[19]. 150 μl of incubation buffer was pipetted into all wells. The absorbance at 450 nm (reference filter 
630 nm or 650 nm) within 1 hour was calculated [20, 21]. 
 
E. Data Analysis 
 
Significant portfolios and issues in the compiled forum have been impeded by all those involved and the 
program has been approved by the SPSS 22.0 program. Normal meanings and genital disorders (SD) are 
calculated for constant changes such as age, height, weight loss and BMI for hypertension (illness and 
disease). In attempting to test the neurotransmitter, fluid variations have been changed between the 
specific parts of the D3 and HbA1C Dioxidal products. In trying to justify the purpose of education, the 
solution is used to determine the relationship between the D and neurotransmitter cells for the two in pairs. 
P <0.05 was uploaded. 
 
I. RESULTS AND DISCUSSION 
 
Often used to talk about the effects of neuropathy on Conductivity velocity (NCV), DL amplitude (AMV), 
acute and nocturnal compression, fast and rapid intensity of the sensory nervous system are all calculated 
by PowerLab in this study. Before Shehab's experiment, he reported that the movement speed of the 
MNCV was the first symptom of the disease [22], whereas before the usual effect, as well as with the 
often reaction, acne is too high [23]. The current part of the time is associated with a cone hologram 
(NCV), the lines and the effect of vitamin D3 on the diagnosis of diabetes. For the most common 
diagnosis, HbA1c was diagnosed with normal people and people with diabetes, as described in Table I.  
In order to find the relationship of HbA1c with Vitamin D3 [24]. Fourth activity in diabetic HbA1c which 
is highly influenced; is achieved. The p-value was highly significant in patients with neuropathy. Table II 
and IV depicts the differences. 
 







Std. Deviation Std. Error Mean P-value 
Blood Glucose Control level 
(RBS) mg/dl 
Patient 
50 1.0298E2 14.56511 2.05982 
 
<0.01 
50 2.1796E2 70.98087 10.03821  
HbA1c (%) Control 
50 5.0480 .40670 .05752 
 
<0.02 
Patient 50 7.3940 1.09422 .15475  
Vitamin D3 level Control ng/ml 50 24.9580 5.41397 .76565 
 
<0.01 
Patient 50 12.4480 3.51970 .49776  
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Likewise, a significant decrease in nerve conduction velocity (NCV) was observed in controls / normal 
subjects [28]. There is no correlation between the age and diabetes [29]. Obviously, a 10% slowdown has 
been reported. This study has shown that serum 25 (OH) vitamin D3 is significantly different in diabetic 
patients and without peripheral neuropathy as shown in the tables in III and V. Several studies separately 
examined the role of each of these factors, diabetic neuropathy. The vitamin D3 deficiency is common in 
patients with diabetes mellitus. Soderstrom (2012) and colleagues studied the role of vitamin D3 in diabetic 
neuropathy. The lack of vitamin D3 in 591 diabetic patients associated with peripheral neuropathy [30]. In 
patients with diabetic neuropathy, reduction in the speed of message relaying activity to the brain is observed. 
The speed of motor nerve reduces in diabetic patients with time and uncontrolled diabetes mellitus… 
Obviously, a 10% glow down has been reported. In this study, the duration of illness in men and women with 
diabetes significantly differs. Age has no significant difference among men and women in diseased condition 
 















Determining the Infringement by Monophilment Sem Weinstein [31] is a "self-report" report. In our study, research 
design was applied and NSS-NDS criteria and electronic tests were used as the minimum criteria for DPN 
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The neuropathy in diabetic patients must have different ways to test the impact of Vitamin D3 tried to change 
neuropathy in the patients [33]. There were certain limitations in our study. At the end of the test, this time the 
connection between neuropathy in diabetic patients with diseased state was expressed; but according to the 
results of the first study of diabetic neuropathy further studies must be conducted to decide the acceptance or 
rejection of the hypothesis. Normally the duration of the disease and the diabetes affects HbA1c. However, no 
difference between genders was observed regarding the disease. The reduction in the speed of message 
relaying activity of diabetic patients occurs due to impairment of nerve conduction velocity.  
 

























D.L AMPT NCV 
Median Nerve 8.12±38.372 22.712±12.122 48.52±1.63 
Ulnar Nerve 2.614±0.478 9.92±2.33 48.42±1.444 
Sural Nerve 2.33±0.292 9.04±3.987 44±3.635 
 Left 
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D.L AMPT NCV 
Median Nerve 2.91±0.612 22.926±12.13 50.78±2.418 
Ulnar Nerve 2.832±0.541 10.402±2.1 51.38±1.455 
Sural Nerve 2.456±0.374 9.402±4.141 46.58±3.569 
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CONCLUSION 
 
The relationship between the deficiency of Vitamin D3 and diabetic neuropathy is assessed in present study. 
The verification of the signal confirms the significance of Vitamin D3 in neuropathy but, assessment of 
Vitamin D3 deficiency and diabetic neuropathy can provide prior assistance regarding human health.  
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